Clinical trial
The Effects of SGLT2 Inhibition on Vascular Health and Physical Function in Veterans With CKD
NCT07060417 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of SGLT2 Inhibition on Vascular Health and Physical Function in Veterans With CKD
- Lead sponsor
- VA Office of Research and Development
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- September 30, 2029
- Enrollment
- 52 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-diabetic chronic kidney disease